Skye Bioscience, Inc. · NASDAQ:SKYE
Schwab Andrew J. sold 375,840 Skye Bioscience, Inc. shares (Form 4)
Traded Aug 18 to Aug 20, 2026 · Filed Aug 20, 2026
From Aug 18 to Aug 20, 2026, Schwab Andrew J. (Director, 10% owner) sold 375,840 Skye Bioscience, Inc. shares, leaving 7,850,155 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 375,840 shares
- Holding after
- 7,850,155 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 45,090 | 1,411,974 | Indirect | |
| Aug 18, 2026 | Common Stock | Sale | 1,830 | 55,663 | Indirect | |
| Aug 18, 2026 | Common Stock | Sale | 253,080 | 7,914,126 | Indirect | |
| Aug 19, 2026 | Common Stock | Sale | 10,255 | 1,401,719 | Indirect | |
| Aug 19, 2026 | Common Stock | Sale | 409 | 55,254 | Indirect | |
| Aug 19, 2026 | Common Stock | Sale | 57,476 | 7,856,650 | Indirect | |
| Aug 20, 2026 | Common Stock | Sale | 1,159 | 1,400,560 | Indirect | |
| Aug 20, 2026 | Common Stock | Sale | 46 | 55,208 | Indirect | |
| Aug 20, 2026 | Common Stock | Sale | 6,495 | 7,850,155 | Indirect |
Source
Related
- Skye Bioscience, Inc.
- Schwab Andrew J.
- Skye Bioscience, Inc. shareholders
- Form 4 · Schwab Andrew J. · Sep 24, 2026
- Form 4 · Schwab Andrew J. · Sep 18, 2026
- Form 4 · 5AM Ventures II LP · Sep 24, 2026
- Form 4 · Parmar Kush · Sep 18, 2026
- Form 4 · 5AM Partners II, LLC · Aug 20, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 18, 2026
- Form 4 · Dhillon Punit · Aug 7, 2026